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Summary 
We used a ‘hit and run* gene targeting strategy to gen- 
erate mice expressing only the ~31 isoform of the con- 
sewed invariant (Ii) chain associated with major his- 
tocompatibility complex (MHC) class II molecules. 
Spleen cells from these mice appear indistinguishable 
from wild type with respect to class II subunit assem- 
bly, transport, peptide acquisition, surface expres- 
sion, and the ability to present intact protein antigens. 
Moreover, these mutant mice have normal numbers of 
thymic and peripheral CD4+ T cells, and intact CD4+ 
T-dependent proliferative responses towards a solu- 
bleantigen. In short, MHCclass II expression and func- 
tion are surprisingly unaffected in mice lacking p41 
invariant chain, implying that the p31 and p41 isoforms 
may be functionally redundant in the intact animal. 
Introduction 
Class II products of the major histocompatibility complex 
(MHC) are responsible for positive selection of CD4+ T 
lymphocytes and govern their responses towards foreign 
pathogens. Class II a6 heterodimers assembled shortly 
after synthesis in the endoplasmic reticulum (ER) are asso- 
ciated with a third polypeptide chain, the invariant (Ii) 
chain, encoded by an unlinked gene (Sung and Jones, 
1981; Kvist et al., 1982; Machamer and Cresswell, 1982). 
The precise contribution of this highly conserved type II 
membrane glycoprotein to the class II pathway has been 
extensively examined in experiments analyzing transfected 
cells (Sekaly et al., 1988; Miller and Germain, 1986; Lot- 
teau et al., 1990; Peterson and Miller, 1990; Teyton et 
al,, 1990; Layet and Germain, 1991; Anderson and Miller, 
1992; Roche et al., 1992) and mice created by gene tar- 
geting in embryonic stem (ES) cells (Bikoff et al., 1993; 
Viville et al., 1993; Elliott et al., 1994). 
A complex picture has emerged concerning the various 
structural and functional contributions by Ii chain to class 
II responses (Cresswell, 1994). In the exceptional case of 
AabApb molecules, Ii chain is essential to promote stability 
of a6 subunit associations(Bikoff et al., 1993,1995; Viville 
et al., 1993), but this activity appears unnecessary for as- 
sembly of other class II dimers (Sekaly et al., 1986; Miller 
and Germain, 1986; Viville et al., 1993; Bijlmakers et al., 
1994a; Hedley et al., 1994; Bikoff et al., 1995). The Ii chain 
escorts newly assembled class II molecules to peripheral 
endocytic vesicles where exposure to acidic pH and pro- 
teolytic enzymes promotes Ii chain degradation and pep- 
tide capture (Baake and Dobberstein, 1990; Lotteau et al., 
1990; Germain and Hendrix, 1991; Roche and Cresswell, 
1991; Neefjes and Ploegh, 1992; Romagnoli et al., 1993; 
Amigorena et al., 1994; Tulp et al., 1994). Ii chain probably 
prevents irreversible misfolding or aggregation (Stern and 
Wiley, 1992; Germain and Rinker, 1993; Bonnerot et al., 
1994) and maintains the groove ready for peptide occu- 
pancy (Roche and Cresswell, 1990, 1991; Teyton et al., 
1990; Roche et al., 1992). Class II molecules produced by 
cells lacking Ii chain are found associated with molecular 
chaperones (Schaiff et al., 1992; Bonnerot et al., 1994; 
Nijenhuis and Neefjes, 1994), exhibit decreased rates of 
export through the secretory pathway to the cell surface 
(Layet and Germain, 1991; Anderson and Miller, 1992; 
Bikoff et al., 1993; Viville et al., 1993; Elliott et al., 1994) 
appear conformationally distinct (Peterson and Miller, 
1990, 1992; Bikoff, 1992; Bikoff et al., 1993; Viville et al., 
1993; Elliott et al., 1994), and behave as if empty or occu- 
pied by an easily displaced peptide (Bikoff et al., 1993; 
Elliott et al., 1994, Busch et al., 1995). 
Class II molecules predominantly expressed by B cells, 
dendritic cells, macrophages, and thymic epithelial cells, 
may also be present on the surface of thyroid follicular 
cells, astrocytes, pancreatic 8 cells, and endothelial cells 
under pathological conditions (PujoCBorrell et al., 1983, 
1987; Pober et al., 1983; Fierz et al., 1985). Although class 
II and Ii chain genes apparently show similar tissue- 
specific patterns of expression (Koch and Harris, 1984) 
and coordinate up-regulation in response to interferon 
(IFN) (Collins et al., 1984; Momburg et al., 1986) and in- 
terleukin4 (IL-4) (Polla et al., 1986), there exists nonethe- 
less considerable evidence suggesting noncoordinate ex- 
pression of class II and Ii chain in selected cell types 
(Momburg et al., 1986, 1988; Kampgen et al., 1991; Vidal 
et al., 1993). 
Overall, the structural organization of human and mouse 
Ii chain genes is remarkably similar. The evolutionarily 
conserved ~31 and p41 isoforms are encoded by alterna- 
tively spliced mRNAs (Strubin et al., 1986; Koch et al., 
1987; O’Sullivan et al., 1987). Additionally, in humans, al- 
ternative translational start sites give rise to four distinct 
Ii chain proteins (Strubin et al., 1986; O’Sullivan et al., 
1987). The additional p41-specific exon 6b encodes a cys- 
teine-rich thyroglobulin-like segment, lying immediately 
adjacent to residues involved in homotrimer formation 
(Bijlmakers et al., 1994b; Bertolino et al., 1995) in a region 
that appears unnecessary for class II associations (Freise- 
winkel et al., 1993; Bijlmakers et al., 1994b; Romagnoli 
and Germain, 1994). It has frequently been suggested that 
the functional activities mediated by these structurally dis- 
tinct Ii chain isoforms might be different. Contradictory 
evidence comes from observations suggesting ~31 and 
p41 are similarly transported inside cells(Romagnoli et al., 
1993; Arunachalam et al., 1993). Additionally, in functional 
experiments, Stockinger et al. (1989) found either p41 or 
~31 alone was sufficient to render class I-expressing fi- 
broblasts capable of antigen presentation. On the other 
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hand, Peterson and Miller (1992) documented selective 
enhancement by p41 of class II antigen presentation. Nu- 
merous experiments demonstrate that the extent of Ii 
chain dependency with respect to antigen presentation 
dependson the particular epitope, or possibly T cell recep- 
tor (TCR) avidity (Nadimi et al., 1991; Peterson and Miller, 
1992; Momburg et al., 1993; Loss et al., 1993; Viville et 
al., 1993; Bodmer et al., 1994; Pinet et al., 1994; Ber-tolino 
et al., 1995). 
To examine the possibility that structurally distinct p31 
and p41 Ii chain isoforms may provide different activities 
affecting class II structure or function under physiological 
conditions, we generated a novel mouse strain expressing 
~31 Ii chain alone via homologous recombination in ES 
cells. We reasoned that high levels of Ii chain expression 
might be necessary to achieve functional reconstitution, 
since a61 oligomeric complexes are assembled as nonam- 
ers (Roche et al., 1991; Lamb and Cresswell, 1992). Eff i- 
cient expression of Ii chain might also prove necessary 
to displace abundant ER chaperones, such as BiP or cal- 
nexin (Schaiff et al., 1992; Anderson and Cresswell, 1994; 
Bonnerot et al., 1994; Nijenhuis and Neefjes, 1994). Rela- 
tively little is known about the cis-acting regulatory se- 
quences controlling constitutive and inducible Ii chain ex- 
pression in diverse cell types. For these reasons, we elected 
to undertake a “hit and run” gene targeting experiment to 
generate mutant mice expressing ~31 alone under control 
of endogenous regulatory elements. Surprisingly, we 
found that class II structure and function in mice exclu- 
sively expressing ~31 Ii chain appear perfectly normal. 
Thus, AabApb molecules, efficiently assembled and trans- 
ported to the cell surface in the absence of p41 are, by all 
present criteria, indistinguishable from wild type. Further 
evidence that ~31 Ii chain has full capacity as a class II 
chaperone comes from our finding of normal numbers of 
thymic and peripheral CD4+ T cells and a vigorous prolifer- 
ative response following immunization with soluble anti- 
gen. Thus, we conclude ~31 Ii chain alone is sufficient 
to promote class II maturation, antigen presentation, and 
CD4+ T cell selection under in vivo conditions. 
Results 
‘Hit and Run” Targeted Mutation Selectively 
Eliminating Exon 6b at the Ii Chain Locus 
To introduce a deletion of exon 6b at the Ii chain locus, 
we used a two-step recombination procedure termed “hit 
and run” (Hasty et al., 1991). The overall design of the 
targeting vector and predicted intermediates are schemat- 
ically shown in Figure 1A. In brief, genomic DNA con- 
taining the desired modification, in this case a deletion of 
exon 6b, was flanked by both positive (neo) and negative 
(HSV-fk) selectable markers. The targeting vector linear- 
ized within the region of homology was expected to recom- 
bine via the free ends. This “hit” event results in partial 
duplication of the locus. Individual G416R colonies are 
screened to identify correctly targeted hit clones. Counter- 
selection in the presenceof FIAU in the second step allows 
recovery of the rare revertants having undergone an in- 
trachromosomal recombination or “run” event, excising 
duplicated sequences and selection cassettes, and re- 
sulting in the generation of the desired allele containing 
a deletion of exon 6b sequences. 
Results of our “hit and run” screen are summarized in 
Tables 1 and 2. Of 163 G41 6R colonies, we identified five 
correctly targeted clones that gave the expected pattern 
on Southern blots (Figure 1 B). However, hybridization with 
a neo probe revealed multiple insertions were present in 
one of these. The four remaining clones were injected 
into blastocysts. Two clones gave extensive coat color 
chimeras; these were counterselected in FIAU to obtain 
revertants. Of 145 FIAUR colonies recovered from clone 
31, 115 were apparently wild type, while eight retained 
the correctly modified allele (Figure 1C). The remaining 
22 subclones gave a more complex pattern of hybridiza- 
tion and were discarded. Of the 136 FIAUR colonies recov- 
ered from clone 125, 130 were wild-type revertants, and 
six subclones retained the mutation. Two run subclones 
derived from clone 31 generated germline chimeras, 
whereas none of the four run subclones derived from clone 
125 transmitted the mutant allele to their offspring. Chime- 
ric males derived from both clones 31-12 and 31-61 were 
crossed to Ii chain-deficient females to generate 31/m 
animals. All results have been confirmed analyzing off- 
spring of both run clones. 
Absence of p41 Ii Chain Expression in Mice Lacking 
Exon6bSequences 
To test whether these mutants selectively express ~31 Ii 
chain, we initially assessed steady-state levels of Ii mRNA 
using an RNAse protection assay that distinguishes alter- 
natively spliced forms of Ii chain mRNA (Bikoff, 1992). 
Thus, mRNA molecules encoding p41 in which exon 6b 
sequences are present, protect the full-length 277 nt frag- 
ment, whereas mRNA encoding ~31 protects a 92 nt frag- 
ment. Mutant lymph node and thymus tissues have no 
detectable signal corresponding to Ii41 and clearly ex- 
press Ii31 mRNA(Figure2A). As judged by hybridization to 
a control mouse actin probe, all these samples contained 
approximately equal amounts of intact mRNA. Thus, we 
conclude that these mutants exhibit a selective loss of Ii41 
transcripts. 
The pattern of Ii chain expression was also examined in 
immunoprecipitation experiments using In-l monoclonal 
antibody (MAb) specific for an epitope located near the 
NH2 terminus, and P4H5 MAb directed against the COOH- 
terminal segment. As shown in Figure 28, under these 
conditions of biosynthetic labeling, mutant lysates contain 
abundant ~31 protein at levels equivalent to that seen in 
wild-type lanes. Reactivity towards both In-l and P4H5 
MAbs strongly argues that these represent properly folded 
~31 Ii chain protein. As anticipated, mutants harboring a 
deletion of exon 6b sequences fail to express any detect- 
able p41 Ii chain protein. As a positive control, anti-H-2Db 
MAbs showed squivalent amounts of class I produced by 
all groups. We thereforeconclude that the introduced exon 
6b deletion caused selective loss of p41 Ii chain ex- 
pression. 
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Figure 1. Two-Step Recombination Procedure Used to Delete Exon 6b Sequences in ES Cells 
(a) The insertion vector contains 6 kb of genomic homology (thick line). The plasmid backbone is represented by the dotted line. Positive and 
negative selectable markers, G416k and HSV-fk, respectively, and their relative transcriptional orientation are indicated. Exons are represented 
by the open rectangles and exon 6b by the closed rectangle. The endogenous target locus is designated by the thin line. The X indicates the site 
of the crossover event resulting in the formation of the hit allele. E and S indicate EcoRl and Sac1 restriction sites, respectively. Double-headed 
arrows indicate the predicted sizes of diagnostic fragments. The arrowheads indicate the positions of PCR primers used for genotyping mutant 
animals. 
(b) Southern blot analysis to identify correctly targeted hit clones. DNA samples from G418k clones were digested with EcoRI. Probe A detects 
only a 10 kb wild-type fragment in nontargeted clones (lanes l-3). Additional hybridization to a 9 kb fragment from the 5’ duplication in the hit 
allele results from insertion of the targeting vector by homologous recombination (lane 4). 
(c) Southern blot analysis to identify run clones. DNA samples from FIALP colonies were digested with Sac1 and hybridized with probe 6. The 
clone analyzed in lane 5 has undergone a run event as indicated by fragments corresponding to the wild-type (7.5 kb) and mutant (6.5 kb) 
chromosomes. The alternative intrachromosomal recombination event restores the locus to wild type and yields only the 7.5 kb band seen in lanes 
6-9. The parental hit clone (lane 10) shows 7.5 kb fragments derived from wild-type and hit chromosomes, as well as the 9.2 kb band unique to 
the insertion. 
Optimal Class II Assembly, Transport, and Peptide 
Occupancy in the Absence of p41 Ii Chain 
Ii chain facilitates a and 6 subunit associations, post-ER 
export, surface expression, and peptide occupancy of 
AabAfY’ molecules (Bikoff et al., 1993, Viville et al., 1993; 
Elliott et al., 1994). To test whether these functions may 
be differentially mediated by p31 and p41 isoforms in the 
intact animal, we next analyzed synthesis and assembly 
of a6 heterodimers by spleen cells exclusively expressing 
p31 Ii chain. To evaluate specifically the ratios of free a 
and 5 subunits and assembled dimers, we used M5/114 
MAb (Bhattacharya et al., 1981) and conformation- 
independent rabbit antibodies directed against determi- 
nants located in the cytoplasmic tailsof the a and 8 chains, 
respectively (Sant et al., 1991). As expected, wild-type 
lysates showed substantial amounts of p31 and p41 Ii 
chain associated with a6 heterodimers. In mutants lacking 
Ii chain, predominantly free Aab and Apb chains were pres- 
ent, confirming the notion that Ii chain promotes assembly 
of AabApb dimers (Figure 3A). Interestingly, substantial 
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Table 1. Frequency of “Hit” Events at the Ii Chain Locus 
Experiment 1 
“Hit” 
G418s Colonies Multiple 
Screened Insertions 
183 1 
Single 
Insertions 
4 
Clones Chimeras 
Injected’ Produced 
31 good 
120 poor 
125 good 
135 moderate 
* The four “hit” clones that contained single copy insertions of the targeting vector were tested by blastocyst injection. Those which produced 
“good” chimeras, as defined by the extent of coat color contribution, were used in the subsequent “run” experiment. 
amounts of AabApb molecules in association with p31 Ii 
chain only were produced by mutants lacking exon 6b 
sequences. Thus, p41 cannot be viewed as essential for 
optimal subunit assembly. 
Subsequent transport was examined using spleen cells 
pulsed for 40 min and chased for 4 hr. As expected, virtu- 
ally all AabApb molecules produced by wild-type spleen 
cells are comprised of mature a and 6 chains that have 
undergone N-linked glycan maturation during transport 
through the medial-Golgi. In mutant cells lacking Ii chain 
we observed immature a and 6 chains showing no bio- 
chemical evidence of having been exported past the cis- 
Golgi (Figure 3B). In unheated wild-type samples, we ob- 
served mature AabApb molecules migrating in the position 
expected for compact dimers. In contrast, mutant cells 
lacking Ii chain expression contained floppy conformers. 
Previous studies have suggested these structurally dis- 
tinct class II molecules may be empty or occupied by an 
easily displaced peptide (Dornmair and McConnell, 1990; 
Sadegh-Nasseri and Germain, 1991; Bikoff et al., 1993; 
Viville et al., 1993; Elliott et al., 1994). As shown in Figure 
38, mutant spleen cells entirely lacking p41 Ii chain can 
efficiently produce compact AabApb dimers. Equivalent re- 
activity towards MU1 14 and Y-3P MAbs specific for dis- 
tinct epitopes contributed by both chains suggest these 
are conformationally similar to mature AabAPb produced 
by wild-type cells. Thus, af3 heterodimers produced in the 
absence of p41 Ii chain are efficiently transported past the 
cis-Golgi and behave as though tightly occupied by an 
appropriate peptide ligand. 
Reconstitution of MHC Class II Surface Expression 
Ii chain appears necessary for optimal class II surface 
expression by normal splenic B cells (Bikoff et al., 1993; 
Viville et al., 1993; Elliott et al., 1994). To test whether 
p31 alone can enhance class II surface expression under 
physiological conditions, spleen cells were stained using 
anti-I-Ab MAbs and analysed by FACS. As shown in Figure 
4, homozygous mutants (m/m) entirely lacking Ii chain ex- 
press markedly reduced amounts of surface class II in 
comparison with that present on wild-type (+I+) cells. In 
contrast heterozygous (+/m) or mutant (31/m) spleen cells 
lacking the p41 isoform showed no significant differences 
in their expression of I-Ab surface antigens. As judged by 
their equivalent reactivity towards 25-9-17 and Y-3P MAbs 
specific for distinct epitopes contributed by both chains, 
surface AabABb molecules produced in the absence of p41 
Ii chain are conformationally similar if not identical to wild 
We. 
Efficient Presentation of Native Protein Antigens 
As predicted by their reduced rates of post-ER export and 
their inability to capture endogenous peptide ligands effi- 
ciently, the class II molecules produced in the absence of 
Ii chain expression are relatively ineffective for presenta- 
tion of native protein antigens. Experiments from Peterson 
and Miller (1992) strongly suggest enhanced antigen pre- 
sentation activity may be selectively mediated by the p41 
isoform. Thus, we were particularly curious to test recon- 
sititution of class II-restricted antigen presentation. Irradi- 
ated spleen cells were assessed for their ability to stimu- 
late IL-2 production or T cell proliferation in the presence 
of a panel of I-Ab-restricted T cells. As shown in Figure 5, 
spleen cells exclusively expressing p31 Ii chain have the 
capacity to present three native protein antigens effi- 
ciently, namely keyhole limpet hemocyanin (KLH), oval- 
bumin (OVA), and immunoglobulin G2aa(lgG2aa). Interest- 
ingly, a significant response directed against endogenous 
IgG2aa was also observed using spleen cells expressing 
only p31 as stimulators. These results extend earlier evi- 
dence that p31 effectively promotes antigen recognition 
by CD4+ T cells (Stockinger et al., 1969). 
Table 2. Frequency of “Run” Events at the Ii Chain Locus 
Experiment 2 “Hit” Clone 
FIALP Colonies 
Screened 
lntrachromosomal Recombination 
Wild-type Mutant Other Events 
“Run” 31 145 115 8” 22 
125 136 130 6 
a Germline chimeras were generated using two of these eight “run” clones. 
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Figure 2. Hit and Run Targeted Mutation Causes Selective Loss of 
p41 Ii Chain Expression 
(a) RNAse protection analysis. The pGEMli41 probe that distinguishes 
Ii31 and Ii41 transcripts, or a control probe specific for cytoplasmic 
actin, were hybridized with total RNA (10 ug) from thymus or lymph 
node tissues as indicated. The arrows indicate positions of predicted 
full-length protected fragments. The smaller product also observed 
using pGEMli41 results from overdigestion at a short (5 nt) AT-rich 
sequence located at the 3’ end of exon 8 (Bikoff, 1992). 
(b) Biosynthetic labeling and immunoprecipitation analysis. Lysates of 
spleen cells labeled for 60 min with [“Slmethionine were precipitated 
using the indicated MAbs and analyzed by SDS-PAGE under reducing 
conditions. 
Complexes solublized by boiling(B) or incubation at room temperature 
(NE) were analyzed by SDS-PAGE under reducing conditions. C and 
ery. We therefore conclude that expression of p31 Ii chain 
F indicate the positions of compact and floppy a8 dimers, respectively. 
alone is sufficient for positive selection of CD4+ T cells. 
ure 6, when thymocytes from mutant mice entirely lacking 
Ii chain expression were triply stained with antiCD4, anti- 
CD& and anti-TCR MAbs, we observed a striking reduc- 
tion in the numbers of mature CD4+CD8- thymocytes, sig- 
nificantly fewer CD4+CD8-, and increased numbers of 
CD4-CD8+ T cells in the periphery, confirming that the Ii 
chain facilitates development of CD4+ T cells. In the case 
of animals expressing only ~31, we detected normal num- 
bersof matureCD4+CDE-Tcells in thethymusand periph- 
CD4+ T Cell Selection in the Absence of p41 Ii Chain 
MHC-encoded class II molecules are essential for thymic 
selection and functional activities of CD4’ T cells (Cos- 
grove et al., 1991; Grusby et al., 1991). Ii chain-deficient 
mice exhibit decreased numbers of mature CD4+ T cells 
in the thymus and periphery (Bikoff et al., 1993; Viville et 
al., 1993; Elliott et al., 1994), suggesting Ii chain plays a 
role during the normal development of CD4’ T cells. To 
gain further insight into possibly diverse functions medi- 
ated by p31 and p41 isoforms, we analyzed Tcell subpopu- 
lations using three-color flow cytometry. As shown in Fig- 
p31 Ii Chain Is Sufficient for Eliciting CD4+ 
T-Dependent Proliferative Responses 
In Vivo 
Results above demonstrate that spleen cells exclusively 
expressing p31 Ii chain can present native protein anti- 
gens to CD4+ T cells. These mutants also contain normal 
numbers of mature CD4+ T cells in the thymus and periph- 
ery. To examine whether p41 Ii chain might nonetheless 
be necessary for activation of naive CD4+ T cells under 
physiological conditions, we tested proliferative responses 
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Figure 4. FACS Analysis of MHC Class II Surface Expression 
Splenocytes from +I+ (1) m/m (2) 31/m (3) or +/m (4) mice were 
stained with biotin-conjugated MAbsfollowed byfluorescein isothiocy- 
anate-conjugated avidin. 
of local draining lymph node populations. As shown in 
Figure 7 following in vivo immunization, lymph node cells 
expressing only the p31 Ii chain gave equivalent prolifera- 
tive responses as those of heterozygous (+/m) littermates. 
Control responses in the presence of two irrelevant anti- 
gens, OVA and rabbit IgG, or upon addition of blocking 
MAb M5/114 (20 uglml), were not significantly above back- 
ground (data not shown). We therefore conclude that p31 
Ii chain alone is sufficient for initiating a vigorous class II- 
restricted CD4+ Tcell response towards a soluble antigen. 
All the experiments above consistently showed stronger 
responses by +/m and 31/m heterozygotes in comparison 
with those in the presence of wild-type (+I+) accessory 
cells. This cannot simply reflect differences in class II mat- 
uration, because in this regard +/m, 31/m, and +I+ all 
consistently gave identical results. Rather, thesesmall but 
reproducible differences in the magnitude of responses 
can be accounted for activities of background gene(s) 
such as the strong Mlsa allele contributed by 129derived 
ES cells (Janeway et al., 1983). 
It has been known for many years that alternatively spliced 
Ii chain transcripts give rise to structurally distinct p31 and 
p41 Ii chain proteins (Strubin et al., 1986; O’Sullivan et 
al., 1987; Koch et al., 1987). The p41 isoform contains an 
additional cysteine-rich thyroglobulin-like segment en- 
coded by exon 6b. The argument can be made that this 
domain provides a specific function, perhaps promoting 
p41 transport via a distinct route, or controlling class II 
structure or function in a discrete cell type. Here, we have 
analyzed functional activities of p31 Ii chain selectively 
under physiological conditions in vivo. 
Using the “hit and run” gene targeting procedure de- 
scribed by Hasty et al. (1991) we selectively deleted exon 
6b sequences via homologous recombination in ES cells 
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Figure 5. Presentation of Native Protein Antigens by Accessory Cells 
Exclusively Expressing p31 Ii Chain 
Irradiatedspleen cells wereadded toculturescontaining I-A9estricted 
T cells as indicated. 
(A and B) Culture supernatants were assayed for IL-2 content in the 
presence of CTLL indicator cells. 
(C and D) Antigen-specific T cell proliferative responses were mea- 
sured by a 16 hr exposure to 1 uCi [W]thymidine. Responses in the 
presence of increasing concentrations of antigen, medium alone, or 
added LPCl myeloma protein (500 pglml) are shown. All results are 
expressed as mean cpm of triplicate cultures. 
and generated mice selectively expressing the p31 iso- 
form. A potentially important point is these mutants pro- 
duce p31 alone under control of endogenous promoter 
and enhancer elements at concentrations roughly equiva- 
lent to wild type. The efficiency of Ii chain expression could 
in theory have a major impact on the resulting phenotype, 
particularly since Ii chain synthesis far exceeds class II 
under physiological conditions. Moreover, quantitative dif- 
ferences in the efficiency of Ii chain expression have been 
shown to influence antigen presentation (Nadimi et al., 
1991). In addition to transcriptional regulatory elements 
located in the 5’ flanking region (reviewed by Glimcher 
and Kara, 1992) an intronic enhancer has been mapped 
using transfection assays (Zhu and Jones, 1990). The 
present strategy leaves intact these transcriptional control 
regions. By all criteriastudied, we found thematureAabApb 
molecules produced by mutants expressing p31 Ii chain 
only were indistinguishable from wild type. Thus, we ob- 
served optimal dimer assembly, post-Golgi transport, and 
surface expression in the absence of ~41. Moreover, these 
mutants have normal numbers of mature CD4+ T cells in 
the thymus and periphery and can generateefficient CD4+ 
T cell-dependent proliferative responses. 
Mice Lacking p41 Invariant Chain 
391 
a Thymus 
CD8 - 
1.7 :m4m 
I~l’:~j$jj@- 
.: : ; ...:~~;;~ 
:. ._:.. ,..:...: :_. ::.. j,, ‘,;‘:. 
.: .’ .;, ;:‘:., 
.s’ 
0 
2.E 
‘CD0 I 
CD4CD6+ 
TCR up - 
10.0 31/m l;i.:;;J$;.gl& .:&g: I .:, .i”, 1:: >.: ,>**;,.;.y : ; /..‘,,.. I , _:. ,: ,, :i ::,. , :: .._. .,. .’ ::. ..I.. .; ‘>: :,n. : ‘:’ ,o 
‘CD6 k 
10.8 :,; +/m 
r;::: :.; .;g!? 
..+f$&,g..~ ;, i: ‘;) 
,. I. ..’ .-:‘.$,:, -: :. .,. ‘: ,; ,/:“. ‘, 
.;, ,. :., 5 
..‘. ‘. 
. . . 
: ::, .J: :., ( .i : . . . 
0 
.‘.. 2.: 
‘,. 
CD6 - 
CD4+CDB 
.,caf 
TCR a!3 - 
1 CD4+CDK 
TCR a6 - 
b Spleen 
CDB - 
6.0 m/m 
\; .,: 
il. 
,‘L-@.j- 
. . 
‘CD8 I 
‘CD8 I, 
22.3 +/m 
CD8 - 
CD4CD0+ 4!L 
TCR a3 - 
( CD4+CDS 
ek t CD4CD8+ 
TCR up - 
TCR a9 --w 
[D~+CD~-A 
“““” /\, 
TCR a6 - 
Figure 6. Reconstitution of Mature CD4+CD8- T Cells in the Thymus and Periphery 
The lefthand panels show dot plots of thymccytes or spleen cells analyzed for CD4 and CD6 expression. The numbers refer to the percentage 
of total cells present in each indicated gate. The righthand panels show single color histograms for TCR expression of cells within the gates. 
Full reconstitution of Ii chain activities is consistent with 
recent observations demonstrating p31 and p41 isoforms 
exhibit identical routes of intracellular transport (Aruna- 
chalam et al., 1993; Romagnoli et al., 1993). Moreover, 
Stockinger et al. (1989) previously demonstrated func- 
tional redundancy of ~31 and p41 in antigen presentation 
assays. Numerous experiments over recent years have 
further analyzed the exact role played by Ii chain during 
antigen presentation. Despite strong evidence that class 
II molecules become peptide occupied in endocytic com- 
partments, (Germain and Hendrix, 1991; Neefjes and 
Ploegh, 1992; Romagnoli et al., 1993; Amigorena et al., 
1994; Tulp et al., 1994; Castellino and Germain, 1995) 
it seems clear nonetheless that foreign antigens can be 
presented via an endogenous class II pathway (Nuchtern 
et al., 1990; Jaraquemadaet al., 1990; Malnati et al., 1992; 
Loss et al., 1993; Pinet et al., 1994). It has also been shown 
that selected epitopes are presented via an Ii chain-inde- 
pendent pathway (Sekaly et al., 1986; Nadimi et al., 1991; 
Bikoff, 1992; Peterson and Miller, 1992; Loss et al., 1993; 
Momburg et al., 1993; Viville et al., 1993; Bodmer et al., 
1994; Pinet et al., 1994; Bertolino et al., 1995). Recent 
experiments suggest ~31 and p41 may be present in dis- 
crete subcellular fractions (Tulp et al., 1994). By far the 
strongest evidence suggesting discrete functions has 
come from the observation that p41 exhibits greater activ- 
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Figure 7. T-Dependent Proliferative Responses Elicited in the Ab- 
sence of p41 Ii Chain 
Mice were injected with KLH (100 ug) in complete Freund’s adjuvant 
at the base of the tail, and 7 days later, inguinal and para-aortic lymph 
node cells (5 x 1 O5 in 200 ul) were cultured in 96well plates. Prolifera- 
tion was assessed after 24 hr by a 16 hr exposure to 1 pCi [3H] thymi- 
dine. Results are expressed as mean cpm of triplicate cultures. Data 
from one of two identical experiments with similar results are shown. 
ity in antigen presentation assays (Peterson and Miller, 
1992). 
The present report describes vigorous CD4+ T cell prolif- 
erative responses elicited in mutant mice expressing only 
p31 Ii chain and seriously challenges the notion that p41 
plays a critical role during antigen presentation under 
these experimental circumstances. It is, of course, possi- 
ble that ~41 II chain contributes an essential function for 
class II biosynthesis or function in a more restricted con- 
text, perhaps acting in association with a particular MHC 
haplotype not examined here. Consistent with this sugges- 
tion, recent experiments have demonstrated striking quali- 
tative and quantitative differences affecting Ii chain and 
CLIP peptide associations with class II allelic variants 
(Chicz et al., 1993; Awa and Cresswell, 1994; Bikoff et 
al., 1995; Sette et al., 1995). Genetic experiments to test 
the various functional activities mediated by p31 alone in 
the context of different MHC haplotypes are in progress. 
Another possibility is that ~41 specifically regulates 
class II structure or function in discrete types of antigen- 
presenting cells, or in response to cytokines. The present 
analysis of class II expression by splenic B cells, thymic 
stromal cells responsible ‘for positive selection, and anti- 
gen-primed lymph node cell populations, has failed to re- 
veal obvious difference in class II antigen presentation 
-I 
caused by the absence of ~41. However, ~41 may be es- 
sential to guide class II structure or function in nonprofes- 
sional accessory cells, such as thyroid follicular cells, 
astrocytes, pancreatic 8 cells, or intestinal epithelial cells, 
under pathological conditions (Pujol-Borrell et al., 1983, 
1987; Pober et al., 1983; Fierz et al., 1985). Perhaps mu- 
tants lacking ~41 Ii chain may exhibit subtle imbalances 
affecting presentation of self-peptides to CD4+ T lympho- 
cytes. Finally, mutants expressing p31 alone may show 
differences in the quality or intensity of antigen-stimulated 
responses, as proved to be the case during phenotypic 
analysis of LMP2-deficient mice (van Kaer et al., 1994). 
Thus, mutant spleen cells lacking the MHC-encoded pro- 
teasome components showed no apparent phenotype 
with respect to constitutive class I surface expression, but 
were far less effective as virally infected CTL target cells. 
Mutant mice exclusively expressing p31 Ii chain in an 
appropriate tissue-specific fashion should prove useful for 
further dissection of the various functions contributed by 
p31 to class II responses in vivo. Overall, we conclude 
that p31 Ii chain alone is a remarkably effective class II 
chaperone. The present experiments strongly suggest a 
high degree of functional redundancy exists with respect 
to p31 and ~41 activities. Direct evidence that ~41 alone 
can reconstitute class II structure and function under phys- 
iological conditions in the intact animal may come from 
experiments analyzing similar mutants exclusively ex- 
pressing ~41 Ii chain. 
Experimental Procedures 
Construction of the Targeting Vector 
The 10 kb EcoRl fragment detectable on genomic Southern blots and 
predicted to contain exons 2-8 of the Ii chain gene (Koch et al., 1987) 
was isolated from a 129 subgenomic library we constructed in Lambda 
Zap Express (Stratagene Cloning Systems, La Jolla, California). A 
subclone pBSli1 ORI containing the entire genomic insert in pBluescript 
KS was used for restriction mapping and construction of the insertion 
vector. Approximately 6 kb of Ii chain genomic homology is contained 
within the 7 kb Sacl-EcoRI fragment of pSSlilORI. We created the 
mutation by deleting the 1 kb Afllll-Sstl1071 fragment encompassing 
exon 6b and flanking intronic sequence. The HSV-tk and neomycin 
resistance genes recovered as a single 3.3 kb Xhol-Sal1 fragment from 
plasmid pSPneo-tk, a cloning intermediate used in the construction of 
pSP73neo-rk 5’3’li (Bikoff et al., 1993) were inserted into the Xhol 
site in the pSP73 vector backbone to generate pli31TC. Plasmid DNA 
was linearized at the unique Spel site within the third intron approxi- 
mately 1.8 kb upstream of the deletion. 
Transfection and Screening of Recombinant ES Cells 
To generate the hit allele, 2 x 1O’CCE ES cells grown on mitomycin- 
treated STOneo feeder cells, were electroporated with 15 pg of linear- 
ized plasmid DNA, and after a 36 hr recovery period, were grown in 
the presence of G418 (200 pglml) for 8 days. Drug-resistant colonies 
were picked and expanded into 24well tissue culture trays as de- 
scribed (Bikoff et al., 1993). To recover revertants, including those 
that had undergone the desired intrachromosomal recombination 
event, we used the protocol described by Ramirez-Solis et al. (1993). 
In brief, correctly targeted G418s ES cells were plated on eight 10 cm 
dishes (lo5 cells/dish) and FIAU (0.1 pM) was added to a single dish 
on the day of plating (day 0) and then to an additional dish on each 
of 7 consecutive days. FlAUs colonies were picked on day 10 onwards 
and expanded in 24well trays. 
DNA was extracted from individual clones and subjected to South- 
ern blot analysis using several restriction enzymes and probe combina- 
tions to verify the integrity of both sides of the “hit and run” loci. Probe 
A is an 800 bp SstllO71-Sac1 fragment lying 5’ of exon 2 and external 
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to the targeting vector. Probe B is an internal 1.2 kb Nsil-EcoRI frag- 
ment near the S’end of the genomic homology. Additionally, we used 
a neo probe derived from pgk-neo. 
Generation of ES Cell Chimeras and Mutant Offspring 
To generate chimeras, recombinant ES cell clones were injected into 
C57BU6 blastocysts. Proven germline chimeric males were crossed 
to Ii chain-deficient females to generate the animals analyzed in the 
present study. In most experiments, we have been able to compare 
+/m and 31/m littermates. As controls, we alSo analyzed wild-type 
(+/+) B.C-9, a strain congenic with C57BU6 but expressing the Igh’ 
allotype of BALE/c, and homozygous Ii chain-deficient (m/m) offspring 
of intercross matings set up at the eighth backcross generation. 
The polymerase chain reaction (PCA) genotyping assay used to 
distinguish wild type and the null allele at the Ii chain locus has been 
described (Bikoff et al., 1993). Additionally, to screen for the novel 
mutation as shown in Figure 1, primers from exon 6 (5’~CCCACCGAG- 
GCTCCACCTAAAG-37 and the intron between exons 6 and 6b 
(5’-CAGCGTGCGGAGAAGAAGAGAC-3’) were designed to yield a 
280 bp band specific for the deletion and a 1.3 kb product correspond- 
ing to the wild-type chromosome. Because amplification of this longer 
product was relatively inefficient, a third primer (B’-CTGGGCCAGGATC- 
TCAGCAGA-3’) derived from inside the deletion was added to yield 
a 660 bp wild-type product. Reactions were carried out for 10 cycles 
for 30 s at 94OC, 30 s at 65OC, 2 min at 72OC, and then 20 cycles 
with the extension time reduced to 1 min. The amplification products 
were resolved on a 2% agarose gel and visualized by ethidium bromide 
staining. 
RNAse Protection Assay 
Riboprobe vectors suitable for the analysis of alternatively spliced Ii 
chain (Bikoff, 1992) and, as a control, mouse 6 actin (Bikofl et al., 
1991) mRNAs have been described. In brief, pGEMli41 contains a 
277 bp Pstl-Bglll fragment from a Ii41 cDNA comprised of exon 6 (92 
nt) and exon 6b (165 nt) sequences. Plasmids digested with EcoRl 
were transcribed using T7 polymerase to yield the 321 nt pGEMli41 
and 366 nt pGEMmAct probes, respectively. Total cellular RNA (10 
pg) was hybridized overnight at 45’C with %P-labeled riboprobes. 
Samples were subsequently digested using RNAse A (40 &ml) and 
RNAse Ti (2 wglml) for 60 min at 30°C in the case of pGEMli41, or 
for 10 min at 25OC following incubation with the actin probe, treated 
with SDS and proteinase K, extracted twice with phenol/chloroform, 
ethanol precipitated, redissolved in buffer containing 60% formamide, 
and analyzed by electrophoresis in a 6% polyacrylamide denatur- 
ing gel. 
Antibodies 
In-l (Koch et al., 1962) was from R. Steinman (The Rockefeller Univer- 
sity, New York), P4H5 (Mehringer et al., 1991) was provided by P. 
Jones (Stanford University, Palo Alto, California), 25-Q-l 7 and 28-l 4-6 
(Ozato and Sachs, 1961) were provided by K. Ozato (National Institute 
of Child Health and Human Development, National Institutesof Health, 
Bethesda, Maryland), 822-249 (HBmmerling et al., 1979) was obtained 
from U. HBmmerling (Sloan-Kettering Memorial Institute, New York), 
M5/114 (Bhattacharya et al., 1961) was given to us by R. Germain 
(National Institute of Allergy and Infectious Diseases, National Insti- 
tutes of Health, Bethesda, Maryland), Y-3P (Janeway et al., 1964) 
was from C. A. Janeway, Jr. Rabbit antisera specific for determinants 
located in the cytoplasmic tails of the a and b chains (Sant et al., 1991) 
were provided by R. Germain (National Institute of Allergy and Infec- 
tious Diseases, National Institutes of Health, Bethesda, Maryland). 
Radiolabellng and lmmunoprecipitation 
Biosynthetic labeling, immunoprecipitations, and SDS-PAGE were 
carried out as described (Germain and Hendrix, 1991). In brief, spleen 
cells were washed with warm Hanks’balanced salt solution containing 
2% fetal calf serum and antibiotics, and resuspended (2 x lO’/ml) in 
warm leucine-free RPM1 1640 supplemented with 4 mM glutamine and 
5% dialyzed fetal calf serum. After 1 hr at 37OC, [3H]leucine was added 
(250 vCi/ml)for 40 min. For pulse-labeled samples, cells were immedi- 
ately harvested, washed twice with ice-cold phosphate-buffered saline, 
and the cell pellet was lysed in buffer containing 1% NP40, 20 mM 
Tris-HCI (pH 7.5), 150 mM NaCI, 5 mM EDTA, 1 mM PMSF. and 10 kg/ 
ml aprotinin. After incubation on ice for 15 min, extracts were cleared of 
nuclei and debris by centrifugation for 30 min at 15,000 rpm. Alterna- 
tively, labeled cells were resuspended in a Sfold excess volume of 
warm RPM1 1640 supplemented as above and containing 10x cold 
leucine, and incubated at 37OC for 4 hr. Lysates were routinely pre- 
cleared once with rabbit anti-mouse IgG (H and L) antibodies (Zymed, 
South San Francisco, California), twice with rabbit anti-rat IgG (H + 
L) antibodies (Zymed, South San Francisco, California), and twice with 
protein A-agarose (GIBCO BRL, Gaithersburg, Maryland) before the 
addition of specific antibodies. In the case of rat MAb M5/114, second- 
ary anti-rat IgG (H and L) antibodies were added to facilitate recovery 
of immune complexes. lmmunoprecipitates were washed three times 
with buffer containing 0.05 M Tris-HCI (pH 6), 0.45 M NaCI, 0.5% 
NP-40, 0.05% Na-azide, and 1 Ng/ml aprotinin, and then solubilized 
in Laemmli buffer containing 2% SDS and 2-ME by treatment either 
for 60 min at room temperature or by heating at 1 OO°C for 10 min as 
indicated in thefigurelegends. Sampleswere analyzed by SDS-PAGE 
using 10% polyacrylamide gels, subsequently treated with EnHance 
(DuPont NEN, Wilmington, Delaware), dried, and exposed to X-ray 
film. 
lmmunofluorescence Analysis 
For single color analysis, spleen cells depleted of erythrocytes by am- 
monium chloride-Tris treatment were incubated on ice with saturating 
amounts of biotin-conjugated anti-l-Ah antibodies followed by fluores- 
cein isothiocyanate-labeled avidin D. Fluorescence was analyzed us- 
ing a FACScan flow cytometer (Becton-Dickinson and Company, 
Mountain View, California), and the data displayed as cell number 
versus log fluorescence. Dead cells and eryihrocytes were eliminated 
from the analysis by appropriate gating. For three-color analysis, sus- 
pensions of thymocytes or spleen cells were incubated on ice with 
anti-CD6-fluorescein isothiocyanate, anti-CD4-phycoeryihrin, biotin- 
ylated anti-TCR (catalog numbers 01044D, 01065B, and 01302D, re- 
spectively, Pharmingen, San Diego, California) followed by streptavi- 
din-Red 670(GIBCO BRL, Gaithersburg, Maryland). Single histogram 
plots of TCR expression for cells with defined levels of CD4 and CD6 
expression were generated using the gates indicated on the CD4 ver- 
sus CD6 dot plots. 
Antigen Presentation Assays 
The I-Ab-restricted T cell hybridomas BDKll.1, specific for KLH 
(Roehm et al., 1962), and 8097.1, spacificforOVA(Hugoet al., 1992), 
were provided by P. Marrack (Howard Hughes Medical Institute, Na- 
tional Jewish Center, Denver, Colorado). IL-2 production wasassessed 
by incubating T cells (5 x lw/well) with irradiated (3300 rads) spleen 
cells (2 x 105/well) in 200 ~1 complete RPM1 1640 supplemented with 
15% fetal calf serum, 10% NCTClOQ, 100 U/ml penicillin, 100 &ml 
streptomycin, 1 mM Na-pyruvate, 15 mM HEPES (pH 7.2), 0.1 mM 
nonessential amino acids, 5 x 10e5 M 2-ME, 2 mM glutamine, and 
increasing concentrations of antigen. Supernatants were collected 
after 20 hr and assayed for IL-2 content in a secondary culture using 
CTLL indicator cells. rH]Thymidine incorporation was measured in 
the presence of 50% primary supernatant. Results shown are mean 
cpm of triplicate cultures. 
The 861-34 T cell clone specific for IgGPa of the a allotype has 
been described (Bikoff and Birshtein, 1966). The long-term KLH T cell 
line was isolated from B.C-9 mice, astrain congenic with C57BU6 but 
expressing the Igh’allotypeof BALB/c, usingexactlythesameprotocol 
as that described in detail for the generation of IgG2a-specific T cells, 
except that starting lymph node cell population was from mice injected 
7 days earlier with KLH (100 pg) subcutaneously at the base of the 
tail. These T cells were maintained by repeated antigen stimulation 
in the presence of irradiated syngeneic spleen cells, followed by short 
periods of rest. To measure antigen-dependent proliferation, rested 
T cells (2 x lO’/well, in the case of clone 861-34, or 5 x IO’ KLH T 
cells/well) were incubated with irradiated spleen ceils (5 x 105 cells/ 
well) in 200 pl of complete RPM1 1640 supplemented as above. Re- 
sponses in the presence of medium alone, added LPCI myeloma 
protein (500 pg/ml), or increasing concentrations of KLH as the antigen 
were measured afler a 48 hr culture period by a 16-18 hr exposure 
to 1 PCi [3H]thymidine. Results are expressed as mean cpm of triplicate 
cultures. 
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